CBA/T6 and DBA/2J mice inoculated with Plasmodium berghei ANKA (PbA) d
evelop cerebral involvement 6-8 days post-inoculation, from which the
CBA mice almost invariably die and the DBA mice recover. Dexamethasone
(DXM; 80 mg/kg) given to inoculated CBA mice twice, on day 3 and agai
n within 48 h, reduced the cerebral symptoms and prevented death from
cerebral malaria. Plasma tumour necrosis factor (TNF) levels, which in
creased at the time of the cerebral symptoms, were also reduced in the
se DXM-treated mice. Intravenously administered Evans Blue, a dye whic
h binds to albumin, diffused extensively across the blood-brain barrie
r only during the period of cerebral symptoms, in proportion to the se
verity of the cerebral symptoms and the disease. In PbA-infected CBA m
ice, cerebral symptoms and the amount of Evans Blue diffusing into the
brain tissue were both reduced by DSM treatment, bur only if the ster
oid was given on day 3 and again within 48 h. Endotoxin injected intra
vascularly into PbA-infected DBA mice after day 5 resulted in an exagg
eration of cerebral symptoms and death between days 6 and 9. Plasma TN
F and the amount of Evans Blue in the brain parenchyma increased above
normal levels in these mice. Endotoxin injections had only minor effe
cts on the severity of the cerebral symptoms in PbA-infected CBA mice
and did not cause the animals to die sooner.